Clinical Trials Browser

Phase 2 × OTHER × Hormone-Resistant Prostate Cancer × Clear all

NCT02844582 2021-01-25

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Terminated

2 enrolled 5 charts

Hormone-Resistant Prostate Cancer